Dr Reddy’s announces launch of Lansoprazole DR Orally Disintegrating Tablets in US market
Hyderabad, Feb 21(UNI) Dr Reddy’s Laboratories Limited, along with its subsidiaries, together on Monday announced the launch of Lansoprazole DR Orally Disintegrating Tablets a therapeutic equivalent generic version of Prevacid SoluTab Delayed- Release Orally Disintegrating Tablets, 15 mg and 30 mg, approved by the U.S. Food and Drug Administration (USFDA).
The Prevacid brand and generic had U.S. sales of approximately USD 87 million MAT for the most recent twelve months ending in December 2020 according to IMS Health, a company release here said.
Dr Reddy’s Lansoprazole DR Orally Disintegrating Tablets are available in 15 mg and 30 mg tablets in unit-dose packages of 100 (10 x 10).
Vivimed Labs Limited receives approval for 1 product from Uzbekistan equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Dr. Reddy s Laboratories Limited ("Dr. Reddy s" or the "Company") (NYSE: RDY)..
Unichem Laboratories Limited receives ANDA approval for Apremilast Tablets
Posted On: 2021-02-18 22:20:25 (Time Zone: Arizona, USA)
Unichem Laboratories Limited has received ANDA approval for its Apremilast Tablets, 10 mg, 20 mg and 30 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Amgen s Otezla® (apremilast) Tablets, 10 mg, 20 mg, and 30 mg.
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
Shares of UNICHEM LABORATORIES LTD. was last trading in BSE at Rs.306 as compared to the previous close of Rs. 306.35. The total number of shares traded during the day was 4756 in over 193 trades.
Pune, Maharashatra, February 17 2021 (Wiredrelease) Kay Dee Market Insights Private Limited –:The research report on the global Canine Arthritis Treatment Market published by Fast Mr demonstrates the crucial aspects that are envisioned to shape the growth of the market in the upcoming years. The market for Canine Ar.